PHR Form 144: Insider Sale of 3,133 Shares Valued $72,950
Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03.
Rhea-AI Filing Summary
Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.
Positive
- Transaction disclosure includes acquisition date, nature (restricted stock vesting), sale date, broker, and aggregate value
- Three‑month sales history provided (1,245 shares sold on 07/17/2025 for $33,472.82), meeting disclosure requirements
Negative
- Key identifying fields missing in the provided excerpt (filer CIK/CCC and issuer name/address/contact information are not shown)
- Limited context: filing contains only securities sale details and attestation; no operational or financial information about the issuer is included
Insights
TL;DR: Routine insider sale tied to recently vested restricted stock; size is negligible relative to outstanding shares.
The filing documents a proposed sale of 3,133 common shares acquired by restricted stock vesting and classified as compensation. At an aggregate value of $72,950.03, this represents roughly 0.0052% of the reported 59,914,473 shares outstanding, indicating the transaction is immaterial to capitalization metrics. A prior sale of 1,245 shares on 07/17/2025 for $33,472.82 is disclosed, satisfying the three‑month sales history requirement. There are no earnings or operational details in this filing to reassess company fundamentals.
TL;DR: Filing appears to satisfy Rule 144 disclosure elements but lacks some issuer/filer identifiers in the provided excerpt.
The notice includes required transaction details: class, number of shares, acquisition date, nature of acquisition (restricted stock vesting), sale date, broker, and recent three‑month sales. However, the provided content omits specific filer identification fields (CIK/CCC) and issuer contact/address information, which are typically present on a complete Form 144. The signer declares no undisclosed material adverse information, consistent with the form's attestation language.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the PHR Form 144 disclose about the proposed sale?
Does the filing show any recent sales by the same person?
Is the broker handling the sale identified?
AI-generated analysis. How Rhea-AI works. Not financial advice.